Off-the-shelf iPSC natural killer-cell therapy: A new chapter for B-cell lymphoma? Editorial
| Authors: | Tix, T.; Rejeski, K. |
| Title: | Off-the-shelf iPSC natural killer-cell therapy: A new chapter for B-cell lymphoma? |
| Keywords: | treatment response; neutropenia; note; rituximab; follow up; cancer immunotherapy; cell infiltration; antineoplastic activity; cytotoxicity; cost effectiveness analysis; health care cost; b cell lymphoma; therapy delay; cell therapy; natural killer cell; drug therapy; toxicity; adaptive immunity; therapy; tumor microenvironment; cytokine release syndrome; induced pluripotent stem cell; human; article; obinutuzumab; chimeric antigen receptor t-cell immunotherapy |
| Journal Title: | The Lancet Haematology |
| Volume: | 12 |
| Issue: | 7 |
| ISSN: | 2352-3026 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2025-07-01 |
| Start Page: | e484 |
| End Page: | e485 |
| Language: | English |
| DOI: | 10.1016/s2352-3026(25)00166-8 |
| PUBMED: | 40610168 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Source: Scopus |
